Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heated Ovarian Treatment Trial
NCT05659381Phase 3Recruiting
- Sponsor
- GOG Foundation
- Start
- Mar 2024
- Primary completion
- Aug 2029
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cisplatin in ovarian cancer, primary peritoneal cancer (PPC), fallopian tube cancer (PFTC), sponsored by GOG Foundation. Started Mar 2024; status: recruiting.
02
Drugs
cisplatin
03
Conditions
ovarian cancerprimary peritoneal cancer (PPC)fallopian tube cancer (PFTC)
Beyond the preview
Go deeper on NCT05659381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05659381.